首页> 外文OA文献 >Effect of pharmacological pupil dilation on measurements and iol power calculation made using the new swept-source optical coherence tomography-based optical biometer
【2h】

Effect of pharmacological pupil dilation on measurements and iol power calculation made using the new swept-source optical coherence tomography-based optical biometer

机译:基于新型扫频光学相干断层扫描的光学生物计对药理学瞳孔扩张对测量和iol功率计算的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose: to determine whether pupil dilation affects biometric measurements and intraocular lens (IOL) power calculation made using the new swept-source optical coherence tomography-based optical biometer (IOLMaster 700©; Carl Zeiss Meditec, Jena, Germany).udProcedures: eighty-one eyes of 81 patients evaluated for cataract surgery were prospectively examined using the IOLMaster 700© before and after pupil dilation with tropicamide 1%. The measurements made were: axial length (AL), central corneal thickness (CCT), aqueous chamber depth (ACD), lens thickness (LT), mean keratometry (MK), white-to-white distance (WTW) and pupil diameter (PD). Holladay II and SRK/T formulas were used to calculate IOL power. Agreement between measurement modes (with and without dilation) was assessed through intraclass correlation coefficients (ICC) and Bland-Altman plots.udResults: mean patient age was 75.17 ± 7.54 years (range: 57–92). Of the variables determined, CCT, ACD, LT and WTW varied significantly according to pupil dilation. Excellent intraobserver correlation was observed between measurements made before and after pupil dilation. Mean IOL power calculation using the Holladay 2 and SRK/T formulas were unmodified by pupil dilation.udConclusions: the use of pupil dilation produces statistical yet not clinically significant differences in some IOLMaster 700© measurements. However, it does not affect mean IOL power calculation.
机译:目的:确定瞳孔扩张是否会影响生物特征测量和使用新的基于扫频光学相干断层扫描的光学生物计(IOLMaster 700©; Carl Zeiss Meditec,耶拿,德国)进行的人工晶状体(IOL)功率计算。ud:程序:80在接受瞳孔扩张1%托尼酰胺治疗之前和之后,使用IOLMaster 700©对81名接受白内障手术评估的患者的一只眼睛进行了前瞻性检查。进行的测量是:轴向长度(AL),中央角膜厚度(CCT),水房深度(ACD),晶状体厚度(LT),平均角膜曲率法(MK),黑白距离(WTW)和瞳孔直径( PD)。 Holladay II和SRK / T公式用于计算IOL功效。通过类内相关系数(ICC)和Bland-Altman图评估测量模式(有无扩张)之间的一致性。 ud结果:平均患者年龄为75.17±7.54岁(范围:57-92)。在确定的变量中,CCT,ACD,LT和WTW随瞳孔扩大而显着变化。在瞳孔扩张前后进行的测量之间观察到极好的观察者内相关性。使用Holladay 2和SRK / T公式计算的平均IOL功效并未因瞳孔扩张而改变。 ud结论:瞳孔扩张的使用在某些IOLMaster 700©测量中产生统计学上的差异,但在临床上没有显着差异。但是,它不会影响平均IOL功率计算。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号